International Service for the Acquisition of Agri-biotech Applications
The International Service for the Acquisition of Agri-biotech Applications (ISAAA) is a non-profit international organization that shares agricultural biotechnology, focusing on genetic engineering.
 | |
| Abbreviation | ISAAA |
|---|---|
| Formation | 1992 |
| Type | Not for profit organization |
| Purpose | Technology transfer, Knowledge Sharing, Capacity Building, Impact Assessment of GM Crops |
| Location |
|
Region served | Worldwide |
Main organ | Board of Directors |
| Website | www |
Structure
editISAAA operates three regional centers; ISAAA SEAsiaCenter, ISAAA AfriCenter and ISAAA AmeriCenter. ISAAA SEAsiaCenter is hosted by the International Rice Research Institute (IRRI) in Los Baños, Laguna, Philippines. This center also serves as the Global Coordination Office as well as the home of the Global Knowledge Center on Crop Biotechnology.[1] ISAAA AfriCenter is hosted by the International Livestock Research Institute (ILRI) located in Nairobi, Kenya.[2] ISAAA AmeriCenter is located in Cornell University, Ithaca, New York. It serves as the administrative and financial headquarters of the organization.
Donor organisations
editThe ISAAA receives funding from both public and private donors. Some of the ISAAA's funding agencies and companies include the USDA, US Grains Council, Monsanto, Bayer, two banks – Fondazione Bussolera in Italy and Ibercaja in Spain, USAID and the Agricultural Biotechnology Support Project II.[3]
Annual Report on the Global Status of Commercialized Biotech/GM Crops
editThe organization releases an annual publication on the global status of commercially approved genetically engineered crops. The publication is authored by Clive James, the founder and chair emeritus of ISAAA. The annual brief provides research on global trends in the adoption of major biotech crops since they were first planted commercially. Various environmental groups have accused the ISAAA of inflating the size and impact of genetically modified crops in their report.[4][5] James says that the report is based on a multiple public and private sources and that he considers it conservative.[4]
The 2015 report says that "18 million farmers planted 179.7 million hectares of biotech crops in 28 countries, a marginal decrease of 1% (1.8 million hectares) from 2014."[6] As per International Service for the Acquisition of Agri-Biotech Applications (ISAAA)'s latest 'Global Status of Commercialized Biotech/ GM Crops in 2017' report, India has the world's fifth largest cultivated area under genetically modified (GM) crops. The country with the highest area under transgenic crops, at 75 mh, is the United States.[citation needed]
GM approval database
editISAAA documents approved GM crops worldwide and presents them in a database available in the organization's website. Each biotech event is featured with a brief description about the crop, trait, transformation method, developer, and summary of regulatory approval. Entries in the database were sourced from Biotechnology Clearing Houses/Regulatory Institutions of approving countries.
Programs
edit- ISAAA Knowledge Center initiative
- Support Projects - The Agricultural Biotechnology Support Project II (ABSP II) and The U.S. Agency for International Development (USAID).
- Special Project: John Templeton Foundation Project
See also
edit- Margaret Karembu - ISAAA AfriCenter Director
References
edit- ^ "Onesite Master".
- ^ "Archived copy" (PDF). Archived from the original (PDF) on 26 March 2012. Retrieved 23 June 2011.
{{cite web}}: CS1 maint: archived copy as title (link) - ^ "ABSPII". Archived from the original on 11 March 2009. Retrieved 11 March 2009.
- ^ a b Reuters Editorial. "Greens accuse biotech industry of inflating GM data". Archived from the original on 11 March 2016. Retrieved 21 September 2016.
{{cite web}}:|author=has generic name (help) - ^ "GMO industry group sees growing global acceptance". Reuters. 13 February 2008. Retrieved 21 September 2016.
- ^ "Acreage for Genetically Modified Crops Declined in 2015". The New York Times. 13 April 2016.